GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Agios Pharmaceuticals Inc (LTS:0HB0) » Definitions » FCF Yield %

Agios Pharmaceuticals (LTS:0HB0) FCF Yield % : -13.35 (As of Dec. 12, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Agios Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Agios Pharmaceuticals's Trailing 12-Month Free Cash Flow is $-330.11 Mil, and Market Cap is $2,473.40 Mil. Therefore, Agios Pharmaceuticals's FCF Yield % for today is -13.35%.

The historical rank and industry rank for Agios Pharmaceuticals's FCF Yield % or its related term are showing as below:

LTS:0HB0' s FCF Yield % Range Over the Past 10 Years
Min: -39.97   Med: -10.67   Max: 5.27
Current: -13.35


During the past 13 years, the highest FCF Yield % of Agios Pharmaceuticals was 5.27%. The lowest was -39.97%. And the median was -10.67%.

LTS:0HB0's FCF Yield % is ranked worse than
51.16% of 1507 companies
in the Biotechnology industry
Industry Median: -12.65 vs LTS:0HB0: -13.35

Agios Pharmaceuticals's FCF Margin % for the quarter that ended in Sep. 2024 was -944.19%.


Agios Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Agios Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agios Pharmaceuticals FCF Yield % Chart

Agios Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.60 -9.95 -22.53 -20.53 -25.23

Agios Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.79 -23.33 -24.44 -11.74 -12.99

Competitive Comparison of Agios Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Agios Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agios Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Agios Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Agios Pharmaceuticals's FCF Yield % falls into.



Agios Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Agios Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-314.561 / 1246.74774252
=-25.23%

Agios Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-84.637 * 4 / 2605.88255
=-12.99%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Agios Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Agios Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Agios Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Agios Pharmaceuticals Business Description

Traded in Other Exchanges
Address
88 Sidney Street, Cambridge, MA, USA, 02139
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

Agios Pharmaceuticals Headlines

No Headlines